Corcept Therapeutics
CORT
CORT
232 hedge funds and large institutions have $1.89B invested in Corcept Therapeutics in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 87 increasing their positions, 77 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% less funds holding
Funds holding: 243 → 232 (-11)
17% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 42
37% less call options, than puts
Call options by funds: $22.5M | Put options by funds: $36M
Holders
232
Holding in Top 10
4
Calls
$22.5M
Puts
$36M
Top Buyers
| 1 | +$49.4M | |
| 2 | +$33.5M | |
| 3 | +$17.2M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$13.7M |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$10.9M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$13.9M | |
| 3 | -$11.1M | |
| 4 |
Renaissance Technologies
New York
|
-$10.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.84M |